University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...

Combining Rituxan with Mavenclad or Zelboraf upfront can extend remissions safely and should become standard first-line therapy for hairy cell leukemia.

Postgraduate Program in Materials Science and Engineering, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte 59078-970, Brazil Department of Physics, Federal University of Rio ...

Every week, slick online ads promise to restore 20/20 vision, reverse memory loss or erase joint pain overnight. The videos tell a familiar story: a lone “doctor” discovers a cure that “big medicine” ...

In 2024, regulators approved Casgevy, the first CRISPR-based therapy to treat sickle cell disease and beta-thalassemia — a one-time treatment that edits a patient’s own stem cells to produce healthy ...

TORRINGTON, CT (WFSB) - A woman was found dead after a fire broke out in a home in Torrington, police confirmed. The victim was identified as Michele Cullen, age 52. Police and the Torrington Fire ...

In the debate over how fast we should be embracing artificial intelligence, one thing comes up again and again. The claim from tech CEOs that AI can cure cancer. So can it? On today's episode, we get ...

A new study has uncovered how tiny differences in boron atoms can help scientists better predict the long-term behavior of glass used to store hazardous waste. The findings, published in Environmental ...

Researchers at King’s College London have created new dietary guidelines for adults with chronic constipation, finding that eating these two foods — and washing them down with the right drink — could ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Sonrotoclax, a BCL2 inhibitor, received FDA breakthrough therapy designation for relapsed or refractory mantle cell lymphoma, indicating its potential to transform patient outcomes. The drug is ...